SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the following meetings:
BIO 2009 Business Forum Date: Tuesday, May 19, 2009 Time: 9:20 a.m. - 9:35 a.m. Eastern Location: Georgia World Congress Center, Room 316, Atlanta, Georgia Speaker: Dr. Dennis Kim, Senior Vice President, Medical Affairs and Communications Eighth Annual JMP Securities Research Conference Date: Tuesday, May 19, 2009 Time: 9:00 a.m. - 9:30 a.m. Pacific Location: The Ritz Carlton, San Francisco Speaker: Graham Cooper, Chief Financial Officer
About Orexigen Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead combination product candidates targeted for obesity are Contrave(R), which is in Phase 3 clinical trials, and Empatic(TM), which is in the later stages of Phase 2 clinical development. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com.
|SOURCE Orexigen Therapeutics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved